S&P 500   4,293.93 (+0.62%)
DOW   33,833.61 (+0.50%)
QQQ   353.15 (+1.24%)
AAPL   180.57 (+1.55%)
MSFT   325.26 (+0.58%)
META   264.58 (+0.37%)
GOOGL   122.14 (-0.29%)
AMZN   124.25 (+2.49%)
TSLA   234.86 (+4.58%)
NVDA   385.10 (+2.76%)
NIO   7.79 (+0.39%)
BABA   86.14 (+1.01%)
AMD   121.05 (+2.73%)
T   16.07 (-0.19%)
F   13.58 (-0.07%)
MU   65.32 (-2.59%)
CGC   0.69 (-3.97%)
GE   106.07 (+-0.01%)
DIS   92.53 (+0.01%)
AMC   4.68 (-1.06%)
PFE   39.09 (+0.51%)
PYPL   64.24 (+0.31%)
NFLX   409.37 (+2.40%)
S&P 500   4,293.93 (+0.62%)
DOW   33,833.61 (+0.50%)
QQQ   353.15 (+1.24%)
AAPL   180.57 (+1.55%)
MSFT   325.26 (+0.58%)
META   264.58 (+0.37%)
GOOGL   122.14 (-0.29%)
AMZN   124.25 (+2.49%)
TSLA   234.86 (+4.58%)
NVDA   385.10 (+2.76%)
NIO   7.79 (+0.39%)
BABA   86.14 (+1.01%)
AMD   121.05 (+2.73%)
T   16.07 (-0.19%)
F   13.58 (-0.07%)
MU   65.32 (-2.59%)
CGC   0.69 (-3.97%)
GE   106.07 (+-0.01%)
DIS   92.53 (+0.01%)
AMC   4.68 (-1.06%)
PFE   39.09 (+0.51%)
PYPL   64.24 (+0.31%)
NFLX   409.37 (+2.40%)
S&P 500   4,293.93 (+0.62%)
DOW   33,833.61 (+0.50%)
QQQ   353.15 (+1.24%)
AAPL   180.57 (+1.55%)
MSFT   325.26 (+0.58%)
META   264.58 (+0.37%)
GOOGL   122.14 (-0.29%)
AMZN   124.25 (+2.49%)
TSLA   234.86 (+4.58%)
NVDA   385.10 (+2.76%)
NIO   7.79 (+0.39%)
BABA   86.14 (+1.01%)
AMD   121.05 (+2.73%)
T   16.07 (-0.19%)
F   13.58 (-0.07%)
MU   65.32 (-2.59%)
CGC   0.69 (-3.97%)
GE   106.07 (+-0.01%)
DIS   92.53 (+0.01%)
AMC   4.68 (-1.06%)
PFE   39.09 (+0.51%)
PYPL   64.24 (+0.31%)
NFLX   409.37 (+2.40%)
S&P 500   4,293.93 (+0.62%)
DOW   33,833.61 (+0.50%)
QQQ   353.15 (+1.24%)
AAPL   180.57 (+1.55%)
MSFT   325.26 (+0.58%)
META   264.58 (+0.37%)
GOOGL   122.14 (-0.29%)
AMZN   124.25 (+2.49%)
TSLA   234.86 (+4.58%)
NVDA   385.10 (+2.76%)
NIO   7.79 (+0.39%)
BABA   86.14 (+1.01%)
AMD   121.05 (+2.73%)
T   16.07 (-0.19%)
F   13.58 (-0.07%)
MU   65.32 (-2.59%)
CGC   0.69 (-3.97%)
GE   106.07 (+-0.01%)
DIS   92.53 (+0.01%)
AMC   4.68 (-1.06%)
PFE   39.09 (+0.51%)
PYPL   64.24 (+0.31%)
NFLX   409.37 (+2.40%)

Axon Enterprise (AXON) Stock Forecast, Price & News

$194.74
-3.14 (-1.59%)
(As of 04:32 PM ET)
Compare
Today's Range
$194.51
$199.00
50-Day Range
$191.86
$227.53
52-Week Range
$83.01
$229.95
Volume
479,108 shs
Average Volume
987,057 shs
Market Capitalization
$14.39 billion
P/E Ratio
103.04
Dividend Yield
N/A
Price Target
$232.64

Axon Enterprise MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.89 Rating Score
Upside/​Downside
18.9% Upside
$232.64 Price Target
Short Interest
Healthy
2.61% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.95mentions of Axon Enterprise in the last 14 days
Based on 7 Articles This Week
Insider Trading
Selling Shares
$21.27 M Sold Last Quarter
Proj. Earnings Growth
36.48%
From $1.59 to $2.17 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.38 out of 5 stars

Industrial Products Sector

54th out of 176 stocks

Ordnance & Accessories, Except Vehicles & Guided Missiles Industry

2nd out of 7 stocks


AXON stock logo

About Axon Enterprise (NASDAQ:AXON) Stock

Axon Enterprise, Inc. is a leading provider of law enforcement technology solutions that enable using less-lethal weapons, body cameras, and cloud-based software. The company's mission is to protect life by providing innovative solutions that increase transparency and accountability in law enforcement. Axon's products and services include body-worn cameras, digital evidence management software, less-lethal weapons, and crime scene investigation tools.

Axon's primary target market is law enforcement agencies in the United States and abroad. The company's key customers include police departments, sheriff's offices, and federal law enforcement agencies. Axon is headquartered in Scottsdale, Arizona, with additional offices in Seattle, Washington, and London, UK. The company was founded in 1993 as TASER International Inc. and rebranded as Axon in 2017. Axon has also been recognized for its corporate social responsibility efforts, including its commitment to reducing the environmental impact of its products and operations.

Axon's management team is led by Chief Executive Officer and founder Patrick (Rick) Smith, who has been with the company since its inception. Before founding Axon, Smith worked as a software engineer at Honeywell and Intel. He has a bachelor's degree in electrical engineering from Harvard University and a master's from Stanford University.

Axon has experienced strong revenue growth over the past few years, driven by law enforcement agencies' adoption of body cameras and digital evidence management software. The company has been reporting increasing revenue each year for the past several years, and in 2022 it reached a milestone reaching meaningful profitability numbers for the first time. Axon's profit margins have also improved over the past few years, with the company reporting a gross margin averaging around 60%. Axon has a relatively low debt and more than enough assets to cover the company's debts. 

Axon's valuation metrics are relatively high compared to its industry peers, reflecting its strong growth prospects and leadership position in the law enforcement technology market. Axon's price-to-earnings ratio and price-to-book ratio are much higher than industry peers. Axon's stock price has experienced significant volatility over the past few years, driven by various factors, including regulatory changes, news events, and earnings reports. 

Axon Enterprise operates in the law enforcement technology industry, providing products and services to improve public safety. The company primarily focuses on producing and selling conducted electrical weapons (CEWs), body-worn cameras, and software solutions designed to streamline the law enforcement process.

The market for law enforcement technology is highly competitive, with major players such as Motorola Solutions, Inc. and Digital Ally Inc. competing for market share. The industry is also highly regulated, with stringent quality control and safety standards in place. Any missteps or quality issues could damage the company's reputation and lead to regulatory action.

One of Axon's key advantages in the market is its strong brand recognition and reputation for quality. The company's body-worn cameras are considered the best in the industry, and its software solutions are highly regarded. In addition, the company has built a loyal customer base over the years, with a significant percentage of its revenue coming from repeat business.

The law enforcement technology industry is facing significant headwinds. The ongoing debate around police reform and the use of force by law enforcement officers has led to increased scrutiny of companies like Axon, and there is a risk that sales could decline as a result. In addition, the industry is facing pressure from lower-cost competitors, and there is a risk that Axon's pricing strategy could become less effective in the face of increasing competition.

Receive AXON Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Axon Enterprise and its competitors with MarketBeat's FREE daily newsletter.

AXON Stock News Headlines

Laser breakthrough could send stock soaring 2,467%
Laser breakthrough could send stock soaring 2,476% Whenever the military develops a breakthrough technology, timely investors could see groundbreaking returns. General Dynamics returned 8,990%... Boeing soared 4,238%... L3Harris shot up 1,628%...
Sell Every Stock, Except ONE (Ticker Revealed)
We saw one of the longest bull markets in history, with the S&P surging well over 800% But now the chickens have come home to roost. However, Jeff Clark couldn’t care less because he ignores almost every single stock in the market.
Axon Enterprise (AXON) Stock Rose 141% in Q1
Axon Enterprise (NASDAQ:AXON) Now Covered by StockNews.com
Axon Enterprise (NYSE:AXON) Now Covered by StockNews.com
Axon Enterprise (AXON) Rose on Revenue Guidance
S&P 500 Analyst Moves: AXON
Axon Enterprise (NASDAQ:AXON) Price Target Raised to $240.00
See More Headlines

AXON Price History

AXON Company Calendar

Last Earnings
5/09/2023
Today
6/08/2023
Next Earnings (Estimated)
8/08/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Ordnance & accessories, except vehicles & guided missiles
Sub-Industry
Systems Software
Current Symbol
NASDAQ:AXON
Employees
3,734
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$232.64
High Stock Price Forecast
$309.00
Low Stock Price Forecast
$155.00
Forecasted Upside/Downside
+17.6%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.89
Research Coverage
9 Analysts

Profitability

Net Income
$147.14 million
Pretax Margin
13.00%

Debt

Sales & Book Value

Annual Sales
$1.19 billion
Cash Flow
$1.40 per share
Book Value
$17.83 per share

Miscellaneous

Free Float
69,378,000
Market Cap
$14.62 billion
Optionable
Optionable
Beta
0.92

Key Executives

  • Patrick W. SmithPatrick W. Smith
    Chief Executive Officer & Director
  • Joshua M. IsnerJoshua M. Isner
    Chief Operating Officer
  • Brittany Bagley
    Chief Financial & Business Officer
  • Hans Moritz
    Vice President-Hardware Research & Development
  • Jeffrey KuninsJeffrey Kunins
    Chief Technology & Product Officer













AXON Stock - Frequently Asked Questions

Should I buy or sell Axon Enterprise stock right now?

9 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Axon Enterprise in the last year. There are currently 1 hold rating and 8 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" AXON shares.
View AXON analyst ratings
or view top-rated stocks.

What is Axon Enterprise's stock price forecast for 2023?

9 equities research analysts have issued 1-year target prices for Axon Enterprise's shares. Their AXON share price forecasts range from $155.00 to $309.00. On average, they expect the company's stock price to reach $232.64 in the next twelve months. This suggests a possible upside of 17.6% from the stock's current price.
View analysts price targets for AXON
or view top-rated stocks among Wall Street analysts.

How have AXON shares performed in 2023?

Axon Enterprise's stock was trading at $165.93 at the beginning of the year. Since then, AXON shares have increased by 19.3% and is now trading at $197.88.
View the best growth stocks for 2023 here
.

Are investors shorting Axon Enterprise?

Axon Enterprise saw a increase in short interest in the month of May. As of May 15th, there was short interest totaling 1,930,000 shares, an increase of 7.8% from the April 30th total of 1,790,000 shares. Based on an average daily trading volume, of 1,140,000 shares, the short-interest ratio is presently 1.7 days.
View Axon Enterprise's Short Interest
.

When is Axon Enterprise's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, August 8th 2023.
View our AXON earnings forecast
.

How were Axon Enterprise's earnings last quarter?

Axon Enterprise, Inc. (NASDAQ:AXON) announced its quarterly earnings data on Tuesday, May, 9th. The biotechnology company reported $0.51 EPS for the quarter, beating analysts' consensus estimates of $0.03 by $0.48. The biotechnology company earned $343.04 million during the quarter, compared to analyst estimates of $312.07 million. Axon Enterprise had a net margin of 10.76% and a trailing twelve-month return on equity of 10.65%.

What guidance has Axon Enterprise issued on next quarter's earnings?

Axon Enterprise updated its FY 2023 earnings guidance on Tuesday, May, 9th. The company provided EPS guidance of for the period. The company issued revenue guidance of $1.44 billion-$1.46 billion, compared to the consensus revenue estimate of $1.44 billion.

What other stocks do shareholders of Axon Enterprise own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Axon Enterprise investors own include Novavax (NVAX), NVIDIA (NVDA), Netflix (NFLX), Alibaba Group (BABA), Micron Technology (MU), TherapeuticsMD (TXMD), ACADIA Pharmaceuticals (ACAD), bluebird bio (BLUE) and Arena Pharmaceuticals (ARNA).

When did Axon Enterprise IPO?

(AXON) raised $251 million in an initial public offering on Thursday, June 11th 2015. The company issued 17,900,000 shares at $13.00-$15.00 per share. Jefferies, Evercore ISI and RBC Capital Markets served as the underwriters for the IPO and JMP Securities and Baird were co-managers.

What is Axon Enterprise's stock symbol?

Axon Enterprise trades on the NASDAQ under the ticker symbol "AXON."

Who are Axon Enterprise's major shareholders?

Axon Enterprise's stock is owned by many different retail and institutional investors. Top institutional investors include BlackRock Inc. (11.27%), State Street Corp (3.22%), Baillie Gifford & Co. (3.20%), Wellington Management Group LLP (1.94%), William Blair Investment Management LLC (1.90%) and Franklin Resources Inc. (1.70%). Insiders that own company stock include Adriane M Brown, Brittany Bagley, Caitlin Elizabeth Kalinowski, Hadi Partovi, Jawad A Ahsan, Jeffrey C Kunins, Joshua Isner, Julie A Cullivan, Luke Larson, Mark W Kroll, Matthew R Mcbrady, Matthew R Mcbrady, Michael Garnreiter and Patrick W Smith.
View institutional ownership trends
.

How do I buy shares of Axon Enterprise?

Shares of AXON stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Axon Enterprise's stock price today?

One share of AXON stock can currently be purchased for approximately $197.88.

How much money does Axon Enterprise make?

Axon Enterprise (NASDAQ:AXON) has a market capitalization of $14.62 billion and generates $1.19 billion in revenue each year. The biotechnology company earns $147.14 million in net income (profit) each year or $1.89 on an earnings per share basis.

How many employees does Axon Enterprise have?

The company employs 3,734 workers across the globe.

How can I contact Axon Enterprise?

Axon Enterprise's mailing address is 20-22 BEDFORD ROW, LONDON X0, WC1R 4JS. The official website for the company is www.axovant.com. The biotechnology company can be reached via phone at (480) 991-0797, via email at ir@axon.com, or via fax at 480-991-0791.

This page (NASDAQ:AXON) was last updated on 6/8/2023 by MarketBeat.com Staff

My Account -